We are live on ! Find out more
CRL icon

Charles River Laboratories

284 hedge funds and large institutions have $3.85B invested in Charles River Laboratories in 2016 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 105 increasing their positions, 120 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,853% more call options, than puts

Call options by funds: $15.5M | Put options by funds: $793K

40% more funds holding in top 10

Funds holding in top 10: 57 (+2)

11% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 27

1% more capital invested

Capital invested by funds: $3.8B → $3.85B (+$47.1M)

0.01% less ownership

Funds ownership: 97.8%97.79% (-0.01%)

1% less funds holding

Funds holding: 286284 (-2)

13% less repeat investments, than reductions

Existing positions increased: 105 | Existing positions reduced: 120

Holders
284
Holders Change
-2
Holders Change %
-0.7%
% of All Funds
7.56%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.19%
New
30
Increased
105
Reduced
120
Closed
27
Calls
$15.5M
Puts
$793K
Net Calls
+$14.7M
Net Calls Change
+$11.5M

CRL Hedge Fund Activity: Q3 2016 in Review

284 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q3 2016, worth a combined $3.85B — up 1.2% from $3.8B a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new CRL positions and 27 closed out — a net gain of 3 holders — while 105 added to existing stakes and 120 trimmed.

The largest buyer was Millennium Management, adding an estimated $59M. The largest seller was Systematic Financial Management, cutting an estimated $40.6M.

  • 284 institutional investors held Charles River Laboratories (CRL) as of Q3 2016, down from 286 in Q2 2016.
  • Funds reported $3.85B of Charles River Laboratories stock for Q3 2016, up 1.2% quarter-over-quarter.
  • 30 funds opened new Charles River Laboratories positions in Q3 2016 and 27 closed out, a net change of +3 holders.
  • The largest Charles River Laboratories buyer in Q3 2016 was Millennium Management, an estimated $59M added.
  • The largest Charles River Laboratories seller in Q3 2016 was Systematic Financial Management, an estimated $40.6M sold.

Based on aggregated 13F filings for Q3 2016.